Connection

Jean-Luc Diehl to Biomarkers

Back to Details
This is a "connection" page, showing publications Jean-Luc Diehl has written about Biomarkers.
Jean-Luc Diehl
Connection Strength
0.128
Biomarkers
  1. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
    View in: PubMed
    Score: 0.040
  2. Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med. 2018 07; 44(7):1061-1070.
    View in: PubMed
    Score: 0.035
  3. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol. 2021; 12:701273.
    View in: PubMed
    Score: 0.011
  4. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021; 16(5):e0252026.
    View in: PubMed
    Score: 0.011
  5. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
    View in: PubMed
    Score: 0.011
  6. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
    View in: PubMed
    Score: 0.011
  7. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.